Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ROIV

Roivant Sciences Ltd

Apr 26 • 04:00PM ET

11.03

Dollar change +0.15
Percentage change 1.38	%

Healthcare • Biotechnology • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJH VXF IBB FXH IWP IJK IWF IWR VHT SCHM

Index	-	P/E	2.12	EPS (ttm)	5.21	Insider Own	31.57%	Shs Outstand	760.14M	Perf Week	5.45%
Market Cap	8.89B	Forward P/E	-	EPS next Y	-1.18	Insider Trans	-1.20%	Shs Float	551.48M	Perf Month	1.75%
Income	4.47B	PEG	-	EPS next Q	-0.28	Inst Own	50.92%	Short Float	8.18%	Perf Quarter	6.36%
Sales	123.24M	P/S	72.12	EPS this Y	550.87%	Inst Trans	2.60%	Short Ratio	6.09	Perf Half Y	29.16%
Book/sh	7.57	P/B	1.46	EPS next Y	-122.64%	ROA	91.47%	Short Interest	45.13M	Perf Year	27.66%
Cash/sh	8.28	P/C	1.33	EPS next 5Y	-	ROE	123.54%	52W Range	8.06 - 13.24	Perf YTD	-1.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	21.79%	ROI	68.29%	52W High	-16.69%	Beta	1.30
Dividend TTM	-	Quick Ratio	27.77	Sales past 5Y	571.16%	Gross Margin	72.86%	52W Low	36.85%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	27.79	EPS Y/Y TTM	411.84%	Oper. Margin	-850.46%	RSI (14)	54.26	Volatility	3.39% 3.57%
Employees	904	Debt/Eq	0.08	Sales Y/Y TTM	185.76%	Profit Margin	3624.14%	Recom	1.17	Target Price	16.08
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	1322.86%	Payout	-	Rel Volume	0.42	Prev Close	10.88
Sales Surprise	16.89%	EPS Surprise	2051.46%	Sales Q/Q	117.80%	Earnings	Feb 13 BMO	Avg Volume	7.41M	Price	11.03
SMA20	0.67%	SMA50	0.78%	SMA200	3.64%	Trades		Volume	3,109,597	Change	1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-15-24	Initiated	Wolfe Research	Outperform	$17
Jan-05-24	Initiated	Piper Sandler	Overweight	$20
Dec-12-23	Initiated	Deutsche Bank	Buy	$14
Oct-17-23	Initiated	Guggenheim	Buy	$17
Jun-08-23	Initiated	BofA Securities	Neutral	$10.50
Oct-27-22	Initiated	JP Morgan	Overweight	$7
May-23-22	Initiated	SVB Leerink	Outperform	$6
Apr-29-22	Initiated	Cantor Fitzgerald	Overweight	$15
Dec-15-21	Initiated	Goldman	Buy	$15
Nov-08-21	Initiated	H.C. Wainwright	Buy	$14
Oct-28-21	Initiated	Citigroup	Buy	$11
Oct-26-21	Initiated	Truist	Buy	$15
Oct-26-21	Initiated	Jefferies	Buy	$10
Oct-26-21	Initiated	Cowen	Outperform

Show Previous Ratings

Apr-25-24 08:00AM	Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis (Business Wire)
Apr-12-24 11:09AM	10 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey)
Apr-02-24 07:00AM	Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million (GlobeNewswire)
Mar-27-24 01:55PM	Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck (The Wall Street Journal) +7.54%
Mar-26-24 06:22PM	Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 (PR Newswire)
08:50AM	Loading…
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:04AM	10 Stocks George Soros and Insiders Are Crazy About (Insider Monkey)
Feb-15-24 02:45AM	Do You Think the Management of Roivant Sciences (ROIV) Can Create Value? (Insider Monkey)
Feb-13-24 07:00AM	Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update (GlobeNewswire)
Feb-10-24 02:55AM	Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares (GuruFocus.com)
Jan-30-24 04:05PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024 (GlobeNewswire)
Dec-27-23 08:05PM	5 High Growth International Stocks to Buy (Insider Monkey)
Dec-20-23 04:30PM	Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease (GlobeNewswire) -7.78%
Dec-14-23 09:00AM	Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
Nov-28-23 07:00AM	Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential (GlobeNewswire)
02:38AM	Loading…
02:38AM	5 Stocks Under $20 To Buy Now (Insider Monkey)
Nov-27-23 08:00AM	Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus (GlobeNewswire)
Nov-14-23 01:00PM	Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2023 Earnings Call Transcript (Insider Monkey)
Nov-13-23 07:00AM	Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update (GlobeNewswire)
Nov-10-23 08:00AM	Roivant Announces Appointment of Mayukh Sukhatme to Its Board of Directors (GlobeNewswire)
Oct-30-23 05:30PM	Roivant to Report Financial Results for the Second Quarter Ended September 30, 2023, and Provide Business Update on Monday, November 13, 2023 (GlobeNewswire)
Oct-24-23 08:00AM	This $5 Billion Biotech Home Run Took Less Than a Year (The Wall Street Journal)
Oct-23-23 03:02PM	Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion (Investopedia) -11.02%
10:31AM	Why Is Roivant Sciences (ROIV) Stock Up Today? (InvestorPlace)
09:52AM	Roche acquires Telavant, rights to bowel disease drug (Yahoo Finance Video)
06:55AM	Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion (The Wall Street Journal)
03:49AM	Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln Deal (The Wall Street Journal)
01:00AM	Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant (GlobeNewswire)
Oct-13-23 08:00AM	Covant Therapeutics Appoints Vincent Hennemand as Chief Executive Officer (GlobeNewswire)
Oct-05-23 05:01AM	Insider Sell: Eric Venker Sells 1,200,000 Shares of Roivant Sciences Ltd (ROIV) (GuruFocus.com) +5.04%
07:00AM	Loading…
Oct-03-23 07:00AM	Vivek Ramaswamys Former Company Is Doing Just Fine Without Him (The Wall Street Journal)
Sep-30-23 05:00AM	Insider Sell: President & COO Eric Venker Sells 500,000 Shares of Roivant Sciences Ltd (ROIV) (GuruFocus.com)
Sep-26-23 06:00AM	Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results (GlobeNewswire) +21.55%
Sep-11-23 08:00AM	Roivant Announces Completion of Redemption of its Outstanding Warrants (GlobeNewswire) -8.65%
Sep-09-23 10:51AM	The Brash Strategy That Made Vivek Ramaswamy a Fortune (The Wall Street Journal)
Aug-17-23 04:05PM	Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants (GlobeNewswire)
Aug-14-23 07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2023, and Provides Business Update (GlobeNewswire)
Aug-03-23 04:05PM	Roivant to Report Financial Results for the Quarter Ended June 30, 2023, and Provide Business Update on Monday, August 14, 2023 (GlobeNewswire)
Aug-02-23 04:05PM	Roivant Announces Redemption of Outstanding Warrants (GlobeNewswire)
Jul-27-23 08:00AM	Telavant, a Roivant Company, Advances Inflammatory Bowel Disease Program with First Patient Dosed in Global Phase 2 Trial of Novel Anti-TL1A Antibody RVT-3101 in Crohns Disease (GlobeNewswire)
Jul-26-23 10:21AM	Big Short Steve Eisman Says the Stock Market Will Continue Surging as No Recession Signs Emerge Here Are 2 Stocks That Analysts Like (TipRanks)
Jul-13-23 05:50PM	Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion (The Wall Street Journal)
Jul-11-23 08:00AM	Roivant Ranks No. 25 on Fast Companys Fifth Annual List of the 100 Best Workplaces for Innovators and is the Winner on the Science and Technology List as a Part of the Best Workplaces for Innovators Program (GlobeNewswire)
Jun-28-23 08:57AM	UPDATE -- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update (GlobeNewswire) +11.27%
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update (GlobeNewswire)
Jun-26-23 04:05PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provide Business Update on Wednesday, June 28, 2023 (GlobeNewswire) -6.33%
Jun-22-23 07:30AM	Roivant Reports Chronic Period Data for RVT-3101 from the TUSCANY-2 Phase 2b Study in Ulcerative Colitis, Demonstrating Improved Efficacy from the Induction to Chronic Period (GlobeNewswire)
Jun-21-23 05:00PM	Roivant to Host Investor Call at 8:00 AM ET on Thursday, June 22 to Review Results from the Chronic Period of TUSCANY-2, a Large Global Phase 2b Study of RVT-3101 (Anti-TL1A Antibody) in Ulcerative Colitis (GlobeNewswire)
May-16-23 07:00AM	Roivant Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old (GlobeNewswire)
Apr-04-23 07:37AM	Lokavant Hires Experienced Leaders to Accelerate Growth Trajectory (Business Wire)
07:37AM	Lokavant Emerges from Roivant Sciences with Multiple Industry Partnerships to Accelerate Impact on Clinical Research (Business Wire)
Mar-28-23 08:00AM	Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients (GlobeNewswire)
Mar-15-23 07:45AM	Roivant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old (GlobeNewswire) +7.91%
Mar-14-23 04:07PM	Roivant to Host Investor Call at 8:00 AM ET on Wednesday, March 15 to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis (GlobeNewswire)
08:00AM	Proteovant Therapeutics to Present Preclinical Data from Estrogen Receptor and IKZF2 Protein Degrader Programs (GlobeNewswire)
Mar-07-23 08:00AM	Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement (GlobeNewswire)
Feb-21-23 08:32PM	Roivant Sciences Announces Change to its Board of Directors (GlobeNewswire)
Feb-13-23 04:17PM	Collecting Pharmas Scraps Can Pay Off for This Biotech (The Wall Street Journal)
07:00AM	Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update (GlobeNewswire)
Feb-02-23 09:14PM	Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares (GlobeNewswire) -11.12%
Feb-01-23 04:05PM	Roivant Sciences Announces Proposed Public Offering of Common Shares (GlobeNewswire)
Jan-30-23 08:00AM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023 (GlobeNewswire)
Jan-04-23 06:05AM	Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2, a Large Global Phase 2b Study of Subcutaneous RVT-3101 for the Treatment of Ulcerative Colitis in Both the Overall and the Biomarker Positive Patient Populations (GlobeNewswire) +5.73%
Dec-07-22 06:30AM	Edison Partners leads $21 million funding round for clinical trial intelligence disruptor Lokavant (PR Newswire)
Dec-01-22 08:00AM	Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases (GlobeNewswire) +8.21%
Nov-14-22 07:00AM	Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update (GlobeNewswire)
Nov-10-22 09:00AM	Affivant to Present Data on AFVT-2101 at 37th Annual Meeting of SITC (GlobeNewswire)
Nov-08-22 06:15AM	Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering (GlobeNewswire) -11.19%
Nov-07-22 04:01PM	Roivant Sciences Announces Proposed Public Equity Offering (GlobeNewswire)
Oct-18-22 04:00PM	Roivant Sciences to Report Financial Results for the Second Quarter Ended September 30, 2022 on Monday, November 14, 2022 and Present at Upcoming Conferences (GlobeNewswire)
Aug-30-22 07:00AM	Roivant to Participate in September Investor Events (GlobeNewswire)
Aug-16-22 11:44AM	Time To Worry? Analysts Are Downgrading Their Roivant Sciences Ltd. (NASDAQ:ROIV) Outlook (Simply Wall St.)
Aug-15-22 07:00AM	Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update (GlobeNewswire)
Aug-14-22 10:53AM	Investors in Roivant Sciences (NASDAQ:ROIV) from a year ago are still down 56%, even after 16% gain this past week (Simply Wall St.)
Aug-03-22 07:00AM	Roivant Sciences to Report Financial Results for the Quarter Ended June 30, 2022 on Monday, August 15, 2022 (GlobeNewswire)
Jul-23-22 09:00AM	Roivant Sciences Ltd.'s (NASDAQ:ROIV) Intrinsic Value Is Potentially 34% Above Its Share Price (Simply Wall St.)
Jun-30-22 09:18AM	Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Are Cutting Their Estimates: Here's What You Need To Know (Simply Wall St.) -9.35%
Jun-28-22 06:27AM	Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges (MarketWatch)
06:10AM	Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 and Provides Business Update (GlobeNewswire)
06:00AM	Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus (GlobeNewswire)
Jun-15-22 04:30PM	Roivant Sciences to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 on Tuesday, June 28, 2022 (GlobeNewswire) +7.90%
May-24-22 06:00AM	FDA Approves Dermavants VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years (GlobeNewswire) +7.12%
May-19-22 04:30PM	Roivant to Present at Upcoming Investor Conferences (GlobeNewswire)
May-16-22 07:00AM	Aruvant Announces Oral Presentation at American Society of Gene and Cell Therapy (ASGCT) (GlobeNewswire)
May-09-22 11:16AM	What Type Of Shareholders Own The Most Number of Roivant Sciences Ltd. (NASDAQ:ROIV) Shares? (Simply Wall St.) -12.71%
May-02-22 07:00AM	Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation (GlobeNewswire)
Apr-20-22 07:00AM	VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders (GlobeNewswire)
Apr-13-22 07:00AM	VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen (GlobeNewswire)
Mar-25-22 08:01AM	Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting (GlobeNewswire)
Mar-24-22 07:00AM	Sanford Burnham Prebys and Roivant Social Ventures Announce Groundbreaking Partnership to Increase Diversity & Inclusion in Biopharma (GlobeNewswire)
Mar-11-22 04:45PM	Roivant to Present at Targeted Protein Degradation Conference (GlobeNewswire)
Mar-07-22 11:18AM	Roivant Sciences (NASDAQ:ROIV) dips 14% this week as increasing losses might not be inspiring confidence among its investors (Simply Wall St.)
Feb-28-22 06:01AM	Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna (GlobeNewswire)
Feb-14-22 07:00AM	Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update (GlobeNewswire) +5.11%
Feb-07-22 07:00AM	Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022 (GlobeNewswire)
Jan-25-22 04:30PM	Roivant to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-05-22 04:30PM	Roivant Licenses Splicing Modulator and Announces Upcoming Presentation at 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.52%
10:39AM	Goldman Sachs Predicts Over 60% Rally for These 3 Stocks (TipRanks)
Dec-16-21 10:00AM	Virtual Reality Startup Nanome Announces Largest Deployment to Date (GlobeNewswire)
Nov-15-21 07:00AM	Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update (GlobeNewswire)

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Venker Eric	President & COO	Feb 09 '24	Option Exercise	3.85	96,950	373,258	629,157	Feb 09 09:00 PM
Venker Eric	President & COO	Feb 09 '24	Sale	10.92	96,950	1,058,694	532,207	Feb 09 09:00 PM
Ramaswamy Vivek	10% Owner	Jan 02 '24	Sale	11.05	3,000,000	33,150,000	51,929,426	Jan 03 04:56 PM
Venker Eric	Chief Operating Officer	Oct 05 '23	Sale	10.11	153,027	1,547,103	595,397	Oct 04 09:30 PM
Venker Eric	Chief Operating Officer	Oct 04 '23	Option Exercise	3.85	153,027	589,154	748,424	Oct 04 09:30 PM
Venker Eric	Chief Operating Officer	Oct 03 '23	Option Exercise	3.85	606,221	2,333,951	1,201,618	Oct 04 09:30 PM
Venker Eric	Chief Operating Officer	Oct 03 '23	Sale	10.25	606,221	6,213,765	595,397	Oct 04 09:30 PM
Venker Eric	Chief Operating Officer	Oct 02 '23	Option Exercise	3.85	440,752	1,696,895	1,036,149	Oct 04 09:30 PM
Roivant Sciences Ltd.	Director	Oct 02 '23	Buy	38.00	1,526,316	58,000,008	79,805,331	Oct 04 05:15 PM
Venker Eric	Chief Operating Officer	Oct 02 '23	Sale	10.80	440,752	4,760,122	595,397	Oct 04 09:30 PM
SVF Investments (UK) Ltd	10% Owner	Sep 28 '23	Sale	12.60	10,000,000	126,000,000	73,031,667	Oct 02 09:00 PM
QVT Financial LP	Director by Deputization	Sep 28 '23	Sale	11.55	10,000,000	115,500,000	100,804	Oct 02 08:43 PM
Gold Daniel Allen	Director	Sep 28 '23	Sale	11.55	10,000,000	115,500,000	100,804	Oct 02 08:55 PM
MANCHESTER KEITH S	Director	Sep 28 '23	Sale	11.55	6,896,144	79,650,463	5,023,787	Oct 02 09:05 PM
Venker Eric	President & COO	Sep 27 '23	Option Exercise	3.85	500,000	1,925,000	1,095,397	Sep 29 09:30 PM
Venker Eric	President & COO	Sep 27 '23	Sale	13.02	500,000	6,510,000	595,397	Sep 29 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Sep 08 '23	Option Exercise	6.48	99,350	643,788	297,300	Sep 12 09:30 PM
Venker Eric	Chief Operating Officer	Sep 08 '23	Option Exercise	3.85	106,430	409,756	718,243	Sep 12 09:32 PM
Venker Eric	Chief Operating Officer	Sep 08 '23	Sale	12.19	106,430	1,297,382	611,813	Sep 12 09:32 PM
Kumar Rakhi	Chief Accounting Officer	Sep 08 '23	Sale	12.18	99,350	1,210,083	197,950	Sep 12 09:30 PM
Venker Eric	Chief Operating Officer	Sep 06 '23	Option Exercise	3.85	5,926	22,815	617,739	Sep 06 09:30 PM
Venker Eric	Chief Operating Officer	Sep 06 '23	Sale	11.85	5,926	70,223	611,813	Sep 06 09:30 PM
Venker Eric	Chief Operating Officer	Sep 05 '23	Option Exercise	3.85	73,275	282,109	685,088	Sep 06 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Sep 05 '23	Option Exercise	6.48	1,724	11,172	199,674	Sep 07 09:30 PM
Venker Eric	Chief Operating Officer	Sep 05 '23	Sale	11.92	73,275	873,438	611,813	Sep 06 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Sep 05 '23	Sale	12.00	1,724	20,688	197,950	Sep 07 09:30 PM
Venker Eric	Chief Operating Officer	Sep 01 '23	Option Exercise	3.85	14,763	56,838	626,576	Sep 06 09:30 PM
Venker Eric	Chief Operating Officer	Sep 01 '23	Sale	11.90	14,763	175,680	611,813	Sep 06 09:30 PM
Venker Eric	Chief Operating Officer	Aug 14 '23	Option Exercise	3.85	59,811	230,272	687,729	Aug 16 09:34 PM
Venker Eric	Chief Operating Officer	Aug 14 '23	Sale	11.89	59,811	711,153	627,918	Aug 16 09:34 PM
Venker Eric	Chief Operating Officer	Aug 03 '23	Option Exercise	3.85	44,629	171,822	672,547	Aug 07 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Aug 03 '23	Option Exercise	6.48	3,681	23,853	203,009	Aug 03 09:30 PM
Venker Eric	Chief Operating Officer	Aug 03 '23	Sale	11.93	44,629	532,424	627,918	Aug 07 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Aug 03 '23	Sale	12.00	3,681	44,172	199,328	Aug 03 09:30 PM
Venker Eric	Chief Operating Officer	Aug 02 '23	Option Exercise	3.85	16,397	63,128	644,315	Aug 02 09:30 PM
Venker Eric	Chief Operating Officer	Aug 02 '23	Sale	11.86	16,397	194,468	627,918	Aug 02 09:30 PM
Venker Eric	Chief Operating Officer	Aug 01 '23	Option Exercise	3.85	61,397	236,378	689,315	Aug 02 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Aug 01 '23	Option Exercise	6.48	336	2,177	199,664	Aug 03 09:30 PM
Venker Eric	Chief Operating Officer	Aug 01 '23	Sale	11.92	61,397	731,852	627,918	Aug 02 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Aug 01 '23	Sale	12.00	336	4,032	199,328	Aug 03 09:30 PM
Venker Eric	Chief Operating Officer	Jul 31 '23	Option Exercise	3.85	117,372	451,882	745,290	Aug 02 09:30 PM
Venker Eric	Chief Operating Officer	Jul 31 '23	Sale	11.91	117,372	1,397,901	627,918	Aug 02 09:30 PM
Venker Eric	Chief Operating Officer	Jul 27 '23	Option Exercise	3.85	23,622	90,945	651,540	Jul 27 09:30 PM
Venker Eric	Chief Operating Officer	Jul 27 '23	Sale	10.98	23,622	259,370	627,918	Jul 27 09:30 PM
Venker Eric	Chief Operating Officer	Jul 26 '23	Option Exercise	3.85	73,568	283,237	701,486	Jul 27 09:30 PM
Venker Eric	Chief Operating Officer	Jul 26 '23	Sale	10.91	73,568	802,627	627,918	Jul 27 09:30 PM
Venker Eric	Chief Operating Officer	Jul 25 '23	Option Exercise	3.85	28,344	109,124	656,262	Jul 27 09:30 PM
Venker Eric	Chief Operating Officer	Jul 25 '23	Sale	10.86	28,344	307,816	627,918	Jul 27 09:30 PM
Venker Eric	President & COO	Jul 24 '23	Option Exercise	3.85	33,081	127,362	677,296	Jul 24 09:31 PM
Venker Eric	President & COO	Jul 24 '23	Sale	10.93	33,081	361,575	644,215	Jul 24 09:31 PM
Venker Eric	President & COO	Jul 21 '23	Option Exercise	3.85	181,998	700,692	826,213	Jul 24 09:31 PM
Venker Eric	President & COO	Jul 21 '23	Sale	11.13	181,998	2,025,638	644,215	Jul 24 09:31 PM
Venker Eric	President & COO	Jul 20 '23	Option Exercise	3.85	159,387	613,640	803,602	Jul 24 09:31 PM
Venker Eric	President & COO	Jul 20 '23	Sale	11.31	159,387	1,802,667	644,215	Jul 24 09:31 PM
Kumar Rakhi	Chief Accounting Officer	Jul 18 '23	Option Exercise	6.48	100	648	82,228	Jul 18 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Jul 18 '23	Sale	12.00	100	1,200	82,128	Jul 18 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Jul 14 '23	Option Exercise	6.48	535	3,467	82,663	Jul 18 09:30 PM
Kumar Rakhi	Chief Accounting Officer	Jul 14 '23	Sale	12.00	535	6,420	82,128	Jul 18 09:30 PM
Sumitomo Chemical Co., Ltd.	10% Owner	Jun 22 '23	Sale	8.60	15,116,277	129,999,982	71,251,083	Jun 26 04:05 PM
VIKING GLOBAL PERFORMANCE LLC	10% Owner	Jun 22 '23	Sale	9.90	13,000,000	128,700,000	641,010	Jun 26 05:10 PM
VIKING GLOBAL INVESTORS LP	10% Owner	Jun 22 '23	Sale	9.90	13,000,000	128,700,000	641,010	Jun 26 05:11 PM
Venker Eric	President & COO	Jun 09 '23	Option Exercise	3.85	299,384	1,152,628	959,481	Jun 09 09:32 PM
Kumar Rakhi	Chief Accounting Officer	Jun 09 '23	Option Exercise	5.12	43,893	224,732	242,475	Jun 13 09:31 PM
Venker Eric	President & COO	Jun 09 '23	Sale	9.91	299,384	2,966,895	660,097	Jun 09 09:32 PM
Kumar Rakhi	Chief Accounting Officer	Jun 09 '23	Sale	9.93	43,893	435,857	198,582	Jun 13 09:31 PM
Venker Eric	President & COO	Jun 07 '23	Option Exercise	3.85	201	774	660,298	Jun 09 09:32 PM
Venker Eric	President & COO	Jun 07 '23	Sale	9.85	201	1,980	660,097	Jun 09 09:32 PM
Venker Eric	President & COO	May 23 '23	Option Exercise	3.85	415	1,598	676,183	May 25 09:30 PM
Venker Eric	President & COO	May 23 '23	Sale	9.85	415	4,088	675,768	May 25 09:30 PM
Venker Eric	President & COO	May 09 '23	Option Exercise	3.85	238,724	919,087	914,492	May 11 09:33 PM
Venker Eric	President & COO	May 09 '23	Sale	9.23	238,724	2,203,423	675,768	May 11 09:33 PM
Venker Eric	President & COO	May 08 '23	Option Exercise	3.85	61,206	235,643	736,974	May 08 09:30 PM
Venker Eric	President & COO	May 08 '23	Sale	8.93	61,206	546,570	675,768	May 08 09:30 PM
Venker Eric	President & COO	May 04 '23	Option Exercise	3.85	88,838	342,026	764,606	May 08 09:30 PM
Venker Eric	President & COO	May 04 '23	Sale	8.30	88,838	737,355	675,768	May 08 09:30 PM
Venker Eric	President & COO	May 03 '23	Option Exercise	3.85	118,760	457,226	794,528	May 03 09:30 PM
Venker Eric	President & COO	May 03 '23	Sale	8.40	118,760	997,584	675,768	May 03 09:30 PM
Venker Eric	President & COO	May 02 '23	Option Exercise	3.85	109,074	419,935	784,842	May 03 09:30 PM
Kumar Rakhi	Chief Accounting Officer	May 02 '23	Option Exercise	3.85	15,517	59,740	215,656	May 03 09:30 PM
Venker Eric	President & COO	May 02 '23	Sale	8.29	109,074	904,223	675,768	May 03 09:30 PM
Kumar Rakhi	Chief Accounting Officer	May 02 '23	Sale	8.42	15,517	130,653	200,139	May 03 09:30 PM
Kumar Rakhi	Chief Accounting Officer	May 01 '23	Option Exercise	3.85	62,219	239,543	262,358	May 03 09:30 PM
Venker Eric	President & COO	May 01 '23	Option Exercise	3.85	61,155	235,447	736,923	May 03 09:30 PM
Kumar Rakhi	Chief Accounting Officer	May 01 '23	Sale	8.58	62,219	533,839	200,139	May 03 09:30 PM
Venker Eric	President & COO	May 01 '23	Sale	8.59	61,155	525,321	675,768	May 03 09:30 PM

Open in Screener

MP

MP Materials Corporation

Apr 26 • 04:00PM ET

16.00

Dollar change -0.03
Percentage change -0.19	%

Basic Materials • Other Industrial Metals & Mining • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

MP MP Materials Corporation daily Stock Chart

Held by: IJH VTI VB VXF VBK REMX SCHA QCLN IJJ VAW

Index	-	P/E	133.89	EPS (ttm)	0.12	Insider Own	24.77%	Shs Outstand	178.08M	Perf Week	-2.74%
Market Cap	2.85B	Forward P/E	37.48	EPS next Y	0.43	Insider Trans	0.00%	Shs Float	133.97M	Perf Month	10.12%
Income	24.31M	PEG	4.15	EPS next Q	-0.03	Inst Own	53.31%	Short Float	23.13%	Perf Quarter	1.14%
Sales	253.44M	P/S	11.24	EPS this Y	-81.20%	Inst Trans	-1.74%	Short Ratio	8.09	Perf Half Y	-7.08%
Book/sh	7.67	P/B	2.09	EPS next Y	482.16%	ROA	1.04%	Short Interest	30.98M	Perf Year	-25.69%
Cash/sh	5.61	P/C	2.85	EPS next 5Y	32.30%	ROE	1.82%	52W Range	12.68 - 26.53	Perf YTD	-19.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	1.18%	52W High	-39.69%	Beta	2.32
Dividend TTM	-	Quick Ratio	9.54	Sales past 5Y	51.37%	Gross Margin	41.44%	52W Low	26.18%	ATR (14)	0.76
Dividend Ex-Date	-	Current Ratio	10.42	EPS Y/Y TTM	-91.58%	Oper. Margin	0.02%	RSI (14)	52.35	Volatility	4.15% 4.85%
Employees	681	Debt/Eq	0.51	Sales Y/Y TTM	-51.95%	Profit Margin	9.59%	Recom	1.70	Target Price	21.28
Option/Short	Yes / Yes	LT Debt/Eq	0.50	EPS Q/Q	-126.42%	Payout	0.00%	Rel Volume	0.58	Prev Close	16.03
Sales Surprise	-9.43%	EPS Surprise	49.11%	Sales Q/Q	-55.81%	Earnings	May 02 AMC	Avg Volume	3.83M	Price	16.00
SMA20	0.15%	SMA50	4.65%	SMA200	-10.99%	Trades		Volume	2,213,742	Change	-0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Downgrade	JP Morgan	Overweight → Neutral	$20 → $16
Mar-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$26 → $15.50
Sep-06-23	Upgrade	Northland Capital	Market Perform → Outperform
Aug-31-23	Initiated	JP Morgan	Overweight	$27
Apr-18-23	Downgrade	Northland Capital	Outperform → Market Perform	$32
Jul-13-22	Initiated	Canaccord Genuity	Buy	$44
Jun-06-22	Resumed	Northland Capital	Outperform	$60
Jun-01-22	Initiated	BMO Capital Markets	Outperform	$50
Feb-09-22	Upgrade	The Benchmark Company	Hold → Buy	$47
Nov-30-21	Resumed	BofA Securities	Buy	$52
Nov-11-21	Initiated	The Benchmark Company	Hold
Nov-11-21	Initiated	Jefferies	Buy	$55
Jul-23-21	Initiated	DA Davidson	Buy	$45
Jun-30-21	Initiated	Robert W. Baird	Outperform	$45
Jun-16-21	Initiated	JP Morgan	Overweight	$41
Apr-01-21	Initiated	BofA Securities	Neutral	$38
Mar-10-21	Initiated	Cowen	Outperform	$50
Mar-09-21	Downgrade	Deutsche Bank	Buy → Hold	$37
Mar-02-21	Initiated	Morgan Stanley	Overweight	$57
Dec-03-20	Initiated	Northland Capital	Outperform	$25

Show Previous Ratings

Apr-25-24 07:36AM	Should You Hold MP Materials (MP) for the Long Term? (Insider Monkey)
Apr-17-24 01:00AM	Australias Richest Person Increases Stake in Lynas Rare Earths (The Wall Street Journal)
Apr-16-24 08:16PM	Australia's Rinehart takes stake in Lynas Rare Earths, shares jump (Reuters)
Apr-11-24 04:05PM	MP Materials Announces Date for First Quarter 2024 Financial Results and Webcast (Business Wire)
Apr-08-24 08:30AM	Do Options Traders Know Something About MP Materials (MP) Stock We Don't? (Zacks) +9.65%
06:00PM	Loading…
Apr-04-24 06:00PM	MP Materials Corp. (MP) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Apr-03-24 07:00PM	The Rare Metal Keeping Biden and Xi Awake at Night (Oilprice.com)
Apr-02-24 11:19AM	MP Materials (MP) Receives $58.5M for Rare Earth Magnet Facility (Zacks)
Apr-01-24 04:40PM	MP Materials Gets $58.5M to Make Rare Earth Magnets in U.S. (IEN) +5.45%
09:05AM	MP Materials Awarded $58.5 Million to Advance U.S. Rare Earth Magnet Manufacturing (Business Wire)
09:00AM	Investors Heavily Search MP Materials Corp. (MP): Here is What You Need to Know (Zacks)
Mar-27-24 09:30AM	Brokers Suggest Investing in MP Materials (MP): Read This Before Placing a Bet (Zacks) +6.37%
Mar-25-24 06:00PM	MP Materials Corp. (MP) Rises As Market Takes a Dip: Key Facts (Zacks)
Mar-21-24 03:28PM	The Top 7 Growth Stocks to Buy if You Want to 5X Your Portfolio (InvestorPlace)
Mar-19-24 09:00AM	MP Materials Corp. (MP) is Attracting Investor Attention: Here is What You Should Know (Zacks)
05:50PM	Loading…
Mar-14-24 05:50PM	MP Materials Corp. (MP) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Mar-11-24 09:30AM	Is It Worth Investing in MP Materials Corp. (MP) Based on Wall Street's Bullish Views? (Zacks)
Mar-08-24 05:50PM	MP Materials Corp. (MP) Stock Moves -0.2%: What You Should Know (Zacks)
09:00AM	MP Materials Corp. (MP) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-05-24 06:16AM	MP Materials Announces Pricing of $650 Million 3.00% Convertible Notes (Business Wire) -8.11%
Mar-04-24 07:00AM	MP Materials Announces Proposed Offering of Convertible Notes (Business Wire)
07:00AM	MP Materials Announces New Share Repurchase Authorization (Business Wire)
Mar-03-24 12:47PM	5 Best Battery Stocks To Invest In Before They Take Off (Insider Monkey)
Feb-26-24 12:55PM	MP Materials (MP) Q4 Earnings Match Estimates, Revenues Miss (Zacks)
09:00AM	MP Materials Corp. (MP) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-23-24 12:10PM	MP Materials Corp. (NYSE:MP) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:30AM	Is MP Materials Corp. (MP) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Feb-22-24 04:56PM	UPDATE 2-MP Materials swings to quarterly loss on falling rare earths prices (Reuters)
04:37PM	MP Materials Corp Reports Mixed Results Amid Market Headwinds (GuruFocus.com)
04:16PM	MP Materials swings to quarterly loss on falling rare earths prices (Reuters)
04:05PM	Loading…
04:05PM	MP Materials Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-20-24 04:05PM	MP Materials to Participate in Upcoming Conferences (Business Wire)
Feb-16-24 05:50PM	MP Materials Corp. (MP) Gains As Market Dips: What You Should Know (Zacks)
Feb-07-24 05:50PM	MP Materials Corp. (MP) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Feb-04-24 04:40PM	UPDATE 5-Australia's Lynas Rare Earths quits tie-up talks with MP Materials (Reuters)
04:25PM	Australia's Lynas Rare Earths confirms discussions with MP Materials (Reuters)
Feb-02-24 11:40PM	Lynas Says It Held Talks With MP Materials on Potential Deal (Bloomberg) +6.37%
Feb-01-24 04:05PM	MP Materials Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Webcast (Business Wire)
Jan-30-24 05:50PM	MP Materials Corp. (MP) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Jan-22-24 05:50PM	MP Materials Corp. (MP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-18-24 06:00PM	MP Materials Corp. (MP) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Jan-08-24 05:50PM	MP Materials Corp. (MP) Advances But Underperforms Market: Key Facts (Zacks)
Jan-02-24 06:00PM	MP Materials Corp. (MP) Declines More Than Market: Some Information for Investors (Zacks)
Dec-30-23 09:17AM	16 Most Volatile Stocks To Buy Now (Insider Monkey)
Dec-19-23 10:51AM	13 Most Promising EV Stocks According To Hedge Funds (Insider Monkey)
Dec-04-23 02:56PM	Billionaire Lee Coopermans 10 Stock Picks with Huge Upside Potential (Insider Monkey)
Nov-26-23 06:13AM	MP Materials Starts Shipping Rare Earth Metals -- at the Worst Time Possible (Motley Fool)
Nov-07-23 09:00AM	MP Materials Corp. (MP) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-03-23 01:33PM	MP Materials Corp. (NYSE:MP) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 05:54PM	MP Materials Corp (MP) Reports Q3 2023 Earnings: Revenue Down 58%, Net Loss of $4.3M (GuruFocus.com) +6.02%
04:41PM	UPDATE 1-MP Materials' adjusted profit beats; rare earths prices sag (Reuters)
04:10PM	MP Materials swings to third-quarter loss on falling rare earths prices (Reuters)
04:05PM	MP Materials Reports Third Quarter 2023 Results (Business Wire)
Oct-31-23 11:51AM	MP Materials (MP) to Report Q3 Earnings: Here's What to Expect (Zacks)
Oct-25-23 05:50PM	MP Materials Corp. (MP) Stock Moves -0.75%: What You Should Know (Zacks)
Oct-23-23 04:05PM	MP Materials to Participate in Upcoming Conferences (Business Wire)
09:00AM	Investors Heavily Search MP Materials Corp. (MP): Here is What You Need to Know (Zacks)
Oct-17-23 08:00AM	Gabelli Funds 47th Annual Auto Symposium October 30th and October 31st (GlobeNewswire)
Oct-13-23 05:50PM	MP Materials Corp. (MP) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Oct-12-23 09:52PM	MP Materials restores separation and refining of rare earths on U.S. soil (CNBC TV)
04:05PM	MP Materials Announces Date for Third Quarter Financial Results and Webcast (Business Wire)
Oct-09-23 09:00AM	Here is What to Know Beyond Why MP Materials Corp. (MP) is a Trending Stock (Zacks)
Oct-06-23 06:00PM	MP Materials Corp. (MP) Stock Sinks As Market Gains: What You Should Know (Zacks)
Oct-03-23 12:10PM	Will MP Materials Corp. (MP) Beat Estimates Again in Its Next Earnings Report? (Zacks) -5.02%
Sep-29-23 05:50PM	MP Materials Corp. (MP) Dips More Than Broader Markets: What You Should Know (Zacks)
02:10PM	14 Best Rare Earth Stocks and ETFs (Insider Monkey)
Sep-27-23 09:00AM	Is Trending Stock MP Materials Corp. (MP) a Buy Now? (Zacks)
Sep-21-23 05:50PM	MP Materials Corp. (MP) Stock Moves -1.05%: What You Should Know (Zacks)
Sep-15-23 05:50PM	MP Materials Corp. (MP) Stock Moves -0.13%: What You Should Know (Zacks)
Sep-14-23 04:05PM	MP Materials to Participate in the D.A. Davidson Diversified Industrials and Services Conference (Business Wire)
Sep-12-23 09:00AM	Is Most-Watched Stock MP Materials Corp. (MP) Worth Betting on Now? (Zacks)
Sep-11-23 08:00AM	Gabelli Funds to Host 47th Annual Automotive Symposium at The Encore at Wynn, Las Vegas, Nevada (GlobeNewswire)
Sep-08-23 05:50PM	MP Materials Corp. (MP) Stock Sinks As Market Gains: What You Should Know (Zacks)
Aug-31-23 04:05PM	MP Materials to Participate in Upcoming Conferences (Business Wire)
Aug-29-23 09:00AM	MP Materials Corp. (MP) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Aug-16-23 09:00AM	MP Materials Corp. (MP) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-07-23 09:09AM	MP Materials Brings Rare-Earth Production Back to America, but at What Cost? (Motley Fool)
Aug-06-23 08:08AM	What You Need To Know About The MP Materials Corp. (NYSE:MP) Analyst Downgrade Today (Simply Wall St.)
Aug-04-23 03:36PM	Why MP Materials Stock Is Soaring Today (Motley Fool) +5.61%
12:01PM	Q2 2023 MP Materials Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-03-23 07:17PM	UPDATE 1-MP Materials profit beats, starts some rare earths refining (Reuters)
05:35PM	MP Materials Corp. (MP) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:17PM	MP Materials profit beats, starts some rare earths refining (Reuters)
04:11PM	MP Materials quarterly profit drops 90% on lower rare earths prices (Reuters)
04:05PM	MP Materials Reports Second Quarter 2023 Results (Business Wire)
Aug-02-23 06:15AM	World battles to loosen China's grip on vital rare earths for clean energy transition (Reuters)
06:00AM	INSIGHT-World battles to loosen China's grip on vital rare earths for clean energy transition (Reuters)
Jul-31-23 12:37PM	MP Materials (MP) to Report Q2 Earnings: What to Expect? (Zacks)
Jul-26-23 07:21PM	The Next Gold Rush: 3 Rare Earth Metals Stocks to Buy Now (InvestorPlace)
05:50PM	MP Materials Corp. (MP) Gains As Market Dips: What You Should Know (Zacks)
01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
09:00AM	Investors Heavily Search MP Materials Corp. (MP): Here is What You Need to Know (Zacks)
Jul-20-23 05:50PM	MP Materials Corp. (MP) Gains As Market Dips: What You Should Know (Zacks)
08:33AM	MP Materials Corp. (MP) Fell 18.8% in Q2 (Insider Monkey)
Jul-17-23 06:00PM	MP Materials Corp. (MP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jul-14-23 09:00AM	Here is What to Know Beyond Why MP Materials Corp. (MP) is a Trending Stock (Zacks)
05:36AM	Could This 1 Stock Be a Winner From China's Possible Export Curbs on Rare Earth Metals? (Motley Fool)
Jul-13-23 04:05PM	MP Materials Announces Date for Second Quarter Financial Results and Webcast (Business Wire)
Jul-11-23 06:15PM	12 Best Mining Stocks Hedge Funds Are Buying (Insider Monkey)
06:00PM	MP Materials Corp. (MP) Gains But Lags Market: What You Should Know (Zacks)

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It owns and operates Mountain Pass, an industrial asset, which is the only rare earth mining and processing site of scale in the Western Hemisphere. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosenthal Michael Stuart	Chief Operating Officer	May 31 '23	Buy	20.69	5,000	103,450	126,622	May 31 04:52 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 30 '23	Buy	21.14	6,000	126,840	121,622	May 31 04:52 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 26 '23	Buy	21.63	7,000	151,410	115,622	May 31 04:52 PM
JHL Capital Group LLC	10% Owner	May 26 '23	Sale	21.70	647,832	14,055,088	0	May 31 04:41 PM
Litinsky James H.	Chairman and CEO	May 26 '23	Sale	21.70	647,832	14,055,088	0	May 31 04:48 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 25 '23	Buy	22.22	5,000	111,100	39,476	May 25 04:31 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 23 '23	Buy	22.03	5,000	110,150	34,476	May 23 06:45 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 22 '23	Buy	21.78	5,000	108,900	29,476	May 22 05:00 PM
Rosenthal Michael Stuart	Chief Operating Officer	May 19 '23	Buy	21.21	10,000	212,100	24,476	May 22 06:08 AM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ROIV

Roivant Sciences Ltd

MP

MP Materials Corporation

Upgrade your FINVIZ experience